 |
 |
 |
 |
 |
 |
 |
 |
 |
Zidovudine (AZT, Retrovir)
Overview
- A Clinical Overview of Zidovudine (AZT, Retrovir) (Regularly Updated)
To read PDF, click here.
From U.S. National Institutes of Health - Prescribing Information for Zidovudine (AZT, Retrovir) Oral Solution (PDF) (November 2009)
From GlaxoSmithKline - Prescribing Information for Zidovudine (AZT, Retrovir) IV Infusion (PDF) (October 2006)
From GlaxoSmithKline
News
- New Dosing Recommendations Retrovir (Zidovudine) Syrup for HIV-Infected Infants (November 6, 2009)
From U.S. Food and Drug Administration - GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S. (November 11, 2008)
If you live in the United States, use private health insurance and take Combivir (AZT/3TC), Epzicom (abacavir/3TC, Kivexa), Lexiva (fosamprenavir, Telzir) or another HIV drug made by GlaxoSmithKline, you may have a chance to save a nice chunk of change.
From GlaxoSmithKline - FDA Approves First Generic HIV/AIDS Drug in Capsule Form for United States Market (March 31, 2006)
From U.S. Food and Drug Administration - WHO Removes Cipla's Lamivudine, Zidovudine Generics From Approved Drug List (June 16, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Research
- Literature Citations for Zidovudine (Regularly Updated)
From U.S. National Institutes of Health - Clinical Trials Using Zidovudine (Regularly Updated)
U.S. and international trials currently recruiting.
From U.S. National Institutes of Health - Studies Raise Possible Long-Term Concern for Infants Exposed to Retrovir in Womb (April 16, 2007)
From aidsmap.com - HIV JournalView: Study Ties Insulin Resistance to NRTIs, Not PIs (September 2005)
d4T and 3TC are associated with insulin resistance and high insulin levels; indinavir is associated only with elevated insulin levels; and no link to insulin abnormalities is found for AZT or ddI.
From The Body PRO - Incidence of Zidovudine-Associated Anemia May Be Lower Than Initially Thought -- Particularly With Fixed-Dose Combinations (July 26, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
Clinical Management
Clinical Management
  |